Co-Founder
Swiss pharmaceutical company
POLY Pharmaceuticals Inc
Switzerland
Ruben is a co-founder of Polyneuron which was founded in 2014. He is the co-inventor of the prototype antiâ€MAG neuropathy drug and an expert on the underlying core technology Antibody-Catch. Since 2013, Ruben’s efforts for Polyneuron have been recognized with several start-up prizes, including the Neurex Support to Start-up , >>venture>> 2014, and the venture kick awards. He is an industrial pharmacist by training who is an expert in the evaluation of novel therapeutic approaches for neuromuscular diseases. He has drug discovery experience including chemical synthesis, assay development, compound screening and profiling, and in vivo pharmacology.
neuromuscular diseases, polyneuron,prototype antiâ€MAG neuropathy drug, pharmacology